Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 1)

v3.20.1
Summary of Significant Accounting Policies (Details 1) - shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Antidilutive securities excluded from computation of earnings per share 8,018,116 1,549,430
Common Stock Options    
Antidilutive securities excluded from computation of earnings per share 307,202 381,412
Series A, H-1, H-3, H-4, I, J and Merger Common Stock Purchase Warrants    
Antidilutive securities excluded from computation of earnings per share 4,300,560 585,306
Series H, H-3, H-4, H-6, Convertible Preferred Stock    
Antidilutive securities excluded from computation of earnings per share 3,410,354 338,069
Restricted Shares (Unvested)    
Antidilutive securities excluded from computation of earnings per share 0 244,643